Description

Nanoparticles can be engineered with distinctive compositions, sizes, shapes, and surface chemistries to enable novel techniques in a wide range of biological applications. The global nanoparticles in biosciences market is set to increase by US$ 47.9 billion from 2022 to 2028, representing a compound annual growth rate (CAGR) of 7.7% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for nanoparticles in biosciences. The global nanoparticles in biosciences market is segmented on the basis of product, and region. On the basis of product, the global nanoparticles in biosciences market has been segmented into drug delivery systems, drug development and formulation, others. Among these, the drug delivery systems segment was accounted for the highest revenue generator in 2021. In terms of geography, the global nanoparticles in biosciences market has been segmented into Asia Pacific, Europe, North America, Rest of the World (RoW). North America is estimated to account for the largest share of the global nanoparticles in biosciences market.

The global nanoparticles in biosciences market is highly competitive. The key players in the nanoparticles in biosciences market include Bristol Myers Squibb Company (BMS), Camurus AB, F. Hoffmann-La Roche AG, GlaxoSmithKline plc (GSK), Merck KGaA, NanoCarrier Co. Ltd., Novartis International AG.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the nanoparticles in biosciences market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: drug delivery systems, drug development and formulation, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global nanoparticles in biosciences market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Nanoparticles in biosciences market overview
Part 3. Market breakdown by product
– Drug delivery systems
– Drug development and formulation
– Others
Part 4. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 5. Key companies
– Bristol Myers Squibb Company (BMS)
– Camurus AB
– F. Hoffmann-La Roche AG
– GlaxoSmithKline plc (GSK)
– Merck KGaA
– NanoCarrier Co., Ltd.
– Novartis International AG
About StrategyHelix
Disclaimer